All articles by Andrew Turley – Page 2

Business
Merck resolves Vytorin case for $688m

2013-02-19T00:00:00Z

Investors say the company knew about Enhance trial failure but withheld information
Business
BMS sells OTC drugs for $482m

2013-02-14T00:00:00Z

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
Business
Ozone device for food packaging

2013-02-12T00:00:00Z

Device uses plasma to create ozone inside sealed packaging
Business
Biogen buys Tysabri from Elan for $3.25bn

2013-02-08T00:00:00Z

Elan earns huge cash injection for blockbuster drug
Business
BASF drops GM potato projects

2013-02-07T00:00:00Z

Move follows transfer of R&D from Europe to US
Business
Reach reviewed: no change required

2013-02-06T00:00:00Z

But disproportionate cost of compliance for small and medium size companies should be reduced, European commission says
Business
Zoetis IPO launches at $2.2bn

2013-02-01T00:00:00Z

Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
Business
DCD in New Zealand milk

2013-01-31T00:00:00Z

Dicyandiamide poses no food risk but fertiliser companies have suspended sales
Business
Sabic invests $500m in new R&D centres

2013-01-30T00:00:00Z

Four centres to be created: two in Saudi Arabia, one in India and one in China
Business
Allergan buys MAP for $958m

2013-01-25T00:00:00Z

Deal strengthens Allergan’s position in neurology with Levadex for treating migraine
Business
OM Group to exit cobalt business

2013-01-24T00:00:00Z

Deal worth up to $435 million includes downstream activities, in particular cobalt refining in Kokkola, Finland
Business
Vasella to leave Novartis in August

2013-01-24T00:00:00Z

Long serving chair of the board of directors will be succeeded by Jörg Reinhardt
Business
Flu vaccine without the eggs approved

2013-01-22T00:00:00Z

Flublok does not require flu virus or eggs for manufacture
Business
UK companies struggling with Reach

2013-01-16T00:00:00Z

Regulation is ‘elephant in the room’ as manufacturers fail to recognise implications
Business
BASF ups Pronova bid

2013-01-16T00:00:00Z

Pronova BioPharma specialises in omega-3 fatty acids
Business
Laropiprant recalled

2013-01-14T00:00:00Z

Merck & Co says it is recalling Tredaptive tablets, approved in the EU for treating patients with high cholesterol
Business
Pharma industry 'strategic crisis'

2013-01-11T00:00:00Z

The problem is shrinking margins, caused by price and cost pressure, regulatory change and expiring patents, report says
Business
Dow Corning to reduce roster by 500

2013-01-10T00:00:00Z

Company says it must respond to oversupplied markets, high raw materials costs and poor growth in many regions
Business
EPA focuses on five chemicals

2013-01-09T00:00:00Z

Risk assessments for five chemicals put out for public consultation
Business
Illumina investment push

2013-01-08T00:00:00Z

$450 million deal for privately owned US firm Verinata Health, which makes chromosomal tests